Effect of a group-based lifestyle intervention on risk factors and insulin resistance for metabolic syndrome

Effect of a group-based lifestyle intervention on risk factors and insulin resistance for metabolic syndrome - Tabaruzaka study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002342

Enrollment

150

Registered

2009-09-01

Start date

2003-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

standard (S: 4-month intervention) intensive intervention (I: 10-month intervention) control group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: people who have at least one or more of the following criteria: obesity (BMI => 25); elevated BP (130 <= SBP < 160 mmHg or 85 <= DBP < 100 mmHg); dyslipidemia (LDL- C => 140 mg/dl, Triglyceride (TG) => 150 mg/dl or HDL-C < 40 mg/dl for male or HDL-C < 50 mg/dl for female); and impaired glucose homeostasis (110 <= FBS < 126 mg/dl, 140 <= BS at 120 min of 75g oral glucose tolerance test (75gOGTT) < 200 mg/dl, or 5.5 <= A1c < 6.1 %)

Exclusion criteria

Exclusion criteria: The subjects who take medication for hypertension, dyslipidemia and diabetes.

Design outcomes

Primary

Measure	Time frame
The effect of components of MS and insulin sensitivity after 10 months and further after 2 years of intervention.	—

Secondary

Measure	Time frame
The effect of BMI, blood pressure, lipid, blood glucose after 10 months and further after 2 years of intervention.	—

Countries

Japan

Contacts

Public ContactTakeshi Nishikawa

Faculty of medical and pharmaceutical sciences, Kumamoto University. Metabolic medicine

takeshi@kumamoto-u.ac.jp+81-96-373-5169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026